NCT01406431

Pharmacokinetic Study of Livalo® Fixed Combination Drug in Healthy Subjects

A Single Dose, Sequence-randomized, Open-label, 2x2 Crossover Study to Compare Pharmacokinetics Between Pitavastatin and Valsartan Co-administration and Livalo® Fixed Combination Drug in Healthy Male Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 48 (actual)
• Sponsor: JW Pharmaceutical · Industry
• Sex: Male
• Age: 20 Years – 55 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to compare pharmacokinetics between Pitavastatin and Valsartan co-administration and Livalo fixed combination drug in healthy male subjects.

Conditions

• Hyperlipidemia
• Hypertension

Interventions

Type	Name	Description
DRUG	Pitavastatin, Valsartan	Pitavastatin 4mg(2 tablets), Valsartan 160mg(1 tablet)
DRUG	Livalo® fixed combination drug	Livalo® fixed combination drug(1 tablet)

Timeline

• Start date: 2011-08-01
• Primary completion: 2011-08-01
• Completion: 2012-10-01
• First posted: 2011-08-01
• Last updated: 2013-01-03

Locations

1 site across 1 country: South Korea